Skip to main content
. 2012 May 4;344:e2856. doi: 10.1136/bmj.e2856

graphic file with name proj003451.f3_default.jpg

Fig 3 Cumulative estimated difference in risk of cardiovascular serious adverse events attributable to varenicline use. Studies ordered by publication year